Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Trevena Inc. | 1 | 13 | 1 | 3 | €0.33 | €8.37 | 2474.277% |
| Pacific Biosciences of California Inc. | 11 | 5 | 4 | 2 | €1.38 | €10.20 | 640.115% |
| Gritstone Oncology Inc | 2 | 2 | 0 | 2 | €0.77 | €6.53 | 750.945% |
| Sangamo Therapeutics Inc. | 11 | 13 | 0 | 2 | €0.49 | €2.79 | 475.113% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 2 | €0.87 | €6.49 | 642.388% |
| Moleculin Biotech Inc | 3 | 27 | 1 | 2 | €0.41 | €18.42 | 4393.659% |
| Emergent Biosolutions Inc. | 2 | 3 | 1 | 2 | €1.80 | €4.62 | 156.571% |
| InVivo Therapeutics Holdings | 1 | 18 | 0 | 1 | €0.32 | €1.60 | 403.145% |
| Sage Therapeutics Inc. | 4 | 3 | 0 | 1 | €12.78 | €43.36 | 239.393% |
| Acadia Pharmaceuticals | 22 | 1 | 2 | 1 | €15.62 | €32.44 | 107.725% |
| Organovo Holdings Inc. | 0 | 5 | 0 | 1 | €0.94 | €3.00 | 219.149% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 1 | €0.65 | €3.00 | 363.106% |
| Vaxart Inc. | 1 | 1 | 1 | 1 | €0.61 | - | - |
| Fibrogen Inc. | 2 | 4 | 1 | 1 | €0.95 | €0.000 | -100.000% |
| Ocuphire Pharma Inc. | 5 | 1 | 0 | 1 | €1.51 | €18.30 | 1111.656% |
| scPharmaceuticals | 3 | 1 | 0 | 1 | €4.02 | €16.43 | 308.716% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 1 | €0.39 | - | - |
| Corvus Pharmaceuticals Inc | 4 | 1 | 1 | 1 | €1.35 | €5.10 | 278.019% |
| BioLase Inc. | 0 | 7 | 0 | 1 | €0.067 | - | - |
| Illumina Inc. | 17 | 4 | 2 | 1 | €114.28 | €177.57 | 55.385% |
| SI-BONE Inc | 15 | 1 | 2 | 1 | €13.70 | €23.59 | 72.188% |
| Pfizer Inc. | 30 | 4 | 3 | 1 | €23.73 | €41.29 | 74.025% |
| Incyte Corp. | 10 | 2 | 1 | 1 | €48.29 | €78.59 | 62.747% |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 1 | €2.38 | €7.00 | 194.118% |
| Orasure Tech | 3 | 1 | 0 | 1 | €5.05 | €8.36 | 65.511% |